For example, Dr. Shiloh said,
preventing Mtb from attaching to receptors on the M - cell surface — such as by vaccinating against a bacterial protein — could block the bacteria's entry, infection, and spread to other organs.
Although further studies are necessary, potential clinical applications of the team's finding would involve developing methods or drugs that
prevent Mtb from entering M - cells.
Not exact matches
The alterations of the rifampin binding site
prevent rifampin from binding to and inhibiting
Mtb RNAP,
preventing rifampin from killing TB bacteria.